Duke medical student Virginie Marchand spent her entire 3rd year at Duke in Tanzania, where she joined a team focused on HIV stigma during labor and delivery.

More than 210,000 people in North Carolina have Alzheimer's disease, and many others have other types of dementia. The North Carolina Registry for Brain Health aims to help relieve the burden by educating North Carolinians, giving them an opportunity to participate in research, and helping researchers recruit study volunteers.

Mary E. Klotman, MD, speaks with Damon Tweedy, MD about how the medical profession can address ongoing concerns about our nation’s mental health.

A large international study led by Duke researchers found that the diabetes drug empagliflozin slowed the time to first hospitalization for heart failure and reduced the total number of subsequent heart failure hospitalizations in patients after they had suffered acute myocardial infarction.

Allan D. Kirk, MD, PhD, FACS, has been awarded the 2024 Flance-Karl Award by the American Surgical Association (ASA). The Flance-Karl Award recognizes surgeons in the U.S. who have made seminal contributions in basic laboratory research which has application to clinical surgery.

A new mathematical model offers hope for better prediction and treatment of Alzheimer’s disease. 

Dr. Klotman shares news about new funding, Match Day, Distinguished Professorships and more.

Scientists at Duke University School of Medicine have long probed the mysteries of RNA, with an eye to harnessing its power for new and better therapies for cancer, diabetes, heart disease and more.

Duke Health is part of a multi-institution research team receiving funding from the federal Advanced Research Projects Agency for Health (ARPA-H) to develop an osteoarthritis treatment that regenerates joints.

Bob Keegan is empowering a pioneering Duke Health team with a transformational gift to kick-start the new Duke Heart Precision and Innovation Collaboratory.